Beijing: Chemical Industry Press (2005)
Lancet 359:20532058 Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, Van Belle E, Committees T, Investigators (2011) Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia
Each administration led to a rapid and marked improvement in withdrawal symptoms, with effects lasting around 3.5 hours [9]
doi:10.1182/blood-2006-08-042531
Bright light and UV exposure can increase the risk of chemical changes over time
Patients on this protocol who also use metabolic support agents like Metformin should note that both agents activate AMPK, and physician oversight is warranted to avoid compounding effects on blood glucose that could theoretically cause hypoglycemia in susceptible individuals, though this has not been reported clinically with MOTS-c at standard doses